These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26540491)

  • 21. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effectiveness of Two Tiotropium Formulations: A Retrospective Cohort Study.
    Spila-Alegiani S; Trotta F; Da Cas R; Rossi M; Venegoni M; Traversa G
    COPD; 2018 Oct; 15(5):418-423. PubMed ID: 30822243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and safety of tiotropium Respimat in the treatment of chronic obstructive pulmonary disease: systematic review].
    Cai HD; Hou J; Lyu YN; Xiong L; Lu MZ; Wu SL
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Aug; 40(8):596-603. PubMed ID: 28810313
    [No Abstract]   [Full Text] [Related]  

  • 24. Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2014 Oct; 74(15):1801-16. PubMed ID: 25300412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV
    Calverley PMA; Mueller A; Fowler A; Metzdorf N; Wise RA
    Ann Am Thorac Soc; 2018 Feb; 15(2):200-208. PubMed ID: 28957643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD.
    Verhamme KM; Afonso A; Romio S; Stricker BC; Brusselle GG; Sturkenboom MC
    Eur Respir J; 2013 Sep; 42(3):606-15. PubMed ID: 23520322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.
    Ohta K; Ichinose M; Tohda Y; Engel M; Moroni-Zentgraf P; Kunimitsu S; Sakamoto W; Adachi M
    PLoS One; 2015; 10(4):e0124109. PubMed ID: 25894430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Dahl R; Engel M; Dusser D; Halpin D; Kerstjens HAM; Zaremba-Pechmann L; Moroni-Zentgraf P; Busse WW; Bateman ED
    Respir Med; 2016 Sep; 118():102-111. PubMed ID: 27578478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
    Ichinose M; Fujimoto T; Fukuchi Y
    Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
    Halpin DM; Kaplan AG; Russell RK
    Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
    Vogelberg C; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Hamelmann E; Engel M; Szefler S
    Respir Res; 2015 Feb; 16(1):20. PubMed ID: 25851298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.
    Tang Y; Massey D; Zhong NS
    Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.
    Selya-Hammer C; Gonzalez-Rojas Guix N; Baldwin M; Ternouth A; Miravitlles M; Rutten-van Mölken M; Goosens LM; Buyukkaramikli N; Acciai V
    Ther Adv Respir Dis; 2016 Oct; 10(5):391-401. PubMed ID: 27405723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study.
    Trotta F; Da Cas R; Rajevic M; Rossi M; Traversa G
    BMJ Open; 2015 May; 5(5):e006619. PubMed ID: 26009573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
    Ma J; Zhou Z; Tang Y; Zhong N
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiotropium Respimat Soft Mist Inhaler versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD.
    Bouloukaki I; Tzanakis N; Mermigkis C; Giannadaki K; Moniaki V; Mauroudi E; Michelakis S; Schiza SE
    Sleep Breath; 2016 May; 20(2):605-12. PubMed ID: 26407963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiotropium HandiHaler in the treatment of COPD: a safety review.
    Kesten S; Celli B; Decramer M; Leimer I; Tashkin D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():397-409. PubMed ID: 20037679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft Mist™ Inhaler in COPD.
    Hodder R; Pavia D; Lee A; Bateman E
    Int J Chron Obstruct Pulmon Dis; 2011; 6():245-51. PubMed ID: 21814460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchodilator Effect of Tiotropium via Respimat
    Ogasawara T; Sakata J; Aoshima Y; Tanaka K; Yano T; Kasamatsu N
    Intern Med; 2017 Sep; 56(18):2401-2406. PubMed ID: 28824055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    Caillaud D; Le Merre C; Martinat Y; Aguilaniu B; Pavia D
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):559-65. PubMed ID: 18268929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.